Company intelligence / Profile preview
Artisan Therapeutics
San Diego, California, United Statesaardvarktherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
In a Phase 2a pilot study of the lead candidate ART-501, 4 out of 6 adult participants with Autism Spectrum Disorder (ASD) showed meaningful signs of clinical benefit. Improvements were noted in behavioral symptoms, including irritability and social withdrawal, as measured by the Aberrant Behavior Checklist (ABC-2). The treatment was reported to be well-tolerated with no serious adverse events.
- Therapeutic areas
- Psychiatry
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Tulex Pharmaceuticals
Beyond the preview
Go deeper on Artisan Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artisan Therapeutics.